郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

病毒感染Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model.

期刊:Parasitology发表年份:2022作者:Lívia Mendes Carvalho; Miriã Rodrigues Gusmão; Ana Flávia Pereira Costa; Rory Cristiane Fortes de Brito; Rodrigo Dian de Oliveira Aguiar-Soares; Jamille Mirelle de Oliveira Cardoso; Alexandre Barbosa Reis; Cláudia Martins Carneiro; Bruno Mendes Roatt

病毒感染Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants.

期刊:Frontiers in immunology发表年份:2023作者:Yongjun Sui; Hanne Andersen; Jianping Li; Tanya Hoang; Yonas Bekele; Swagata Kar; Mark G Lewis; Jay A Berzofsky

病毒感染Salmonella-mediated oral delivery of multiple-target vaccine constructs with conserved and variable regions of SARS-CoV-2 protect against the Delta and Omicron variants in hamster.

期刊:Microbes and infection发表年份:2023作者:Khristine Kaith Sison Lloren; Vijayakumar Jawalagatti; Chamith Hewawaduge; Sivasankar Chandran; Ji-Young Park; John Hwa Lee

病毒感染CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.

期刊:Scientific reports发表年份:2021作者:Chia-En Lien; Yi-Jiun Lin; Charles Chen; Wei-Cheng Lian; Tsun-Yung Kuo; John D Campbell; Paula Traquina; Meei-Yun Lin; Luke Tzu-Chi Liu; Ya-Shan Chuang; Hui-Ying Ko; Chun-Che Liao; Yen-Hui Chen; Jia-Tsrong Jan; Hsiu-Hua Ma; Cheng-Pu Sun; Yin-Shiou Li